Xenetic Biosciences XBIO
NASDAQ XBIO
$2.02 +0.00 (+0.25%)
As of: Oct 21, 2026 · 3:59 PM EDT

Xenetic Biosciences (XBIO) Other financing activities (2015)

Updated

Xenetic Biosciences' Other financing activities was $12,093 in FY2016, down 60.9% from $30,933 in FY2015.

Analysis

Xenetic Biosciences (XBIO) Other financing activities (2015) Analysis & Trends

  • Per Business Quant data, Other financing activities in earlier years was $30,933 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Xenetic Biosciences 4.61 Mn -21.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -1.00
API Access

Xenetic Biosciences Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=XBIO&period=max&api_key=YOUR_API_KEY